APA ציטוט

Gu, J., Qian, L., Zhang, G., Mahajan, N. P., Owonikoko, T. K., Ramalingam, S. S., & Sun, S. (2020). Inhibition of ACK1 delays and overcomes acquired resistance of EGFR mutant NSCLC cells to the third generation EGFR inhibitor, osimertinib. Lung Cancer.

Citação norma Chicago

Gu, Jiajia, Luxi Qian, Guojing Zhang, Nupam P. Mahajan, Taofeek K. Owonikoko, Suresh S. Ramalingam, and Shi-Yong Sun. "Inhibition of ACK1 Delays and Overcomes Acquired Resistance of EGFR Mutant NSCLC Cells to the Third Generation EGFR Inhibitor, Osimertinib." Lung Cancer 2020.

ציטוט MLA

Gu, Jiajia, et al. "Inhibition of ACK1 Delays and Overcomes Acquired Resistance of EGFR Mutant NSCLC Cells to the Third Generation EGFR Inhibitor, Osimertinib." Lung Cancer 2020.